FDA Approves Ensifentrine, Novel Treatment for Chronic Obstructive Pulmonary Disease
On June 26, 2024, the FDA approved ensifentrine (Ohtuvayre) for the treatment of COPD.
FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications
The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.
Supplement Snapshot: Vitamin D and Respiratory Tract Infections
Recent research on vitamin D supplementation and respiratory tract infections can help guide pharmacists in counseling patients.
The Perils of Frivolous Lawsuits
Current rules governing lawsuits must be revisited to strike a balance between legitimate and frivolous legal actions against health care providers.
OTC Product Roundup: Topical Analgesics
Whether patients present with complaints of an aching muscle from a workout or a sudden twinge in the back, consider recommending these topical analgesics.
Examining Barriers to Assessing and Treating Pain in Pediatric Patients
Although there has recently been an effort to improve pediatric pain treatment, it is still often underestimated and not adequately managed.
Beyond Blood Glucose: Addressing Adolescent Diabetes Challenges
Social pressures, physiological changes, mental health challenges, and burnout all complicate diabetes management among adolescents.
FDA Approves First-Ever OTC Hearing Aid Software
Over 30 million American adults experience some hearing loss, yet only one-fifth benefit from hearing aids; the FDA’s approval will expand access to the technology for the patient population.
Major Drug Distributors to Pay $300 Million in Opioid Epidemic Settlements
McKesson, Cardinal Health, and Cencora will share the settlement payment, resolving claims that the companies were significantly involved in fueling the US opioid epidemic.
FDA Authorizes IND For Phase 2 Clinical Trial Evaluating Treatment for Post–COVID-19 Condition
Bezisterim acts on inflammatory signaling pathways and may be a viable treatment option for post–COVID-19 condition, or long COVID.
Q&A: How Health Care Providers Can Help Increase COVID-19 Vaccine Uptake
Chijioke Bennett, executive director of clinical development at Novavax, discusses how health care providers can increase awareness around the importance of COVID-19 vaccines.
Q&A: NACDS President and CEO on PBM Reform and Grassroots Advocacy
The National Association of Chain Drug Stores is active at both the federal and state levels in advocating for PBM reform.
A Diabetes Intervention in Community Pharmacy Drives Value-Based Health Care
A collaboration with Blue Cross and Blue Shield of North Carolina focused on commercial populations has improved care and lowered costs in the state.
